Search for: "Bayer Pharma Aktiengesellschaft"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
21 Oct 2007, 7:40 pm
Bayer Aktiengesellschaft et al. 1:07-cv-05875; filed October 17, 2007 in the Northern District... [read post]
27 Jan 2013, 11:59 pm
Bayer Pharma Aktiengesellschaft v Genentech, Inc. [2012] FCA 1467 (20 December 2012)The Australian Federal Court has ruled that biotechnology company Genentech Inc can serve a claim of infringement of an Australian patent on Regeneron Pharmaceuticals Inc at the address of its New York headquarters. [read post]
21 Apr 2013, 1:42 am
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013] FCA 279 (4 April 2013)Dr James Rowe has had over 30 years’ experience in the pharmaceutical industry. [read post]
20 Mar 2017, 6:39 pm
In Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 250, Bayer was awarded damages of over $25m plus interest, assessed on Bayer’s pre-tax losses. [read post]
26 Jul 2014, 9:14 pm
We continue to await decisions from the Australian court in both the Myriad and the Research Affiliates cases.While the delays in deciding these cases are not inconsiderable, they do not appear to be particularly unusual by current standards of the Full Court – another recently-decided patents appeal, Generic Health Pty Ltd v Bayer Pharma Aktiengesellschaft [2014] FCAFC 73, was heard on 26-27 August 2013, with judgment handed down on 19 May 2014. [read post]
28 Apr 2013, 8:08 am
Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2) [2013] FCA 279 (4 April 2013)The Federal Court has again confirmed that, contrary to the impression you might obtain from reading IP Australia’s Patent Examiners Manual, ‘obvious’ or ‘worthwhile’ to try does not form part of the test for inventive step under Australian patent law. [read post]
16 Jun 2010, 3:02 pm
Novartis Animal Health US, Inc (Docket Report) US: Finding ORGANIC ASPIRIN deceptively misdescriptive of and deceptive for dietary supplements, TTAB sustains Bayer opposition: Bayer Aktiengesellschaft v. [read post]
13 Aug 2009, 6:57 am
Hence, the Board argues, the skilled expert would, having read the patent, still need to do a complete research programme in order to find that out.It appears to be a case of bad claim drafting: The wording merely appears to reflect the fantasy of an employee at Bayer Schering Pharma Aktiengesellschaft, desperately eager to cover each and every solution to the objective of stimulating some enzyme but who has no idea as to which compounds in particular might be suitable to… [read post]
24 Jun 2017, 8:08 pm
These issues were recently considered by Justice Jagot in the Federal Court decision Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 250, who confirmed that ‘the words “reasonable skill and knowledge” require the specification as framed to be in the form in which a person, with reasonable skill in drafting patent specifications and a knowledge of the relevant law and practice, would produce given the patentee's knowledge of… [read post]
29 Aug 2006, 4:13 pm
"Lots of patents, such as pharma patents, are the subject of increasingly restrictive regulations. [read post]
9 Nov 2015, 4:00 am
The Federal Court of Appeal in Bayer Schering Pharma Aktiengesellschaft v. [read post]
30 Mar 2022, 4:31 am
In two separate judgments, the Full Court has provided much needed clarity on how to identify the pharmaceutical products that can support a valid patent term extension in Australia, as Natalie Shoolman, Kent Teague and Rose Jenkins explain in this article. [read post]
15 Jan 2008, 3:06 am
There were 140 patent cases filed in the Northern District during 2007, an 11% increase from the 126 patent cases filed in 2006. [read post]
